The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...
CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...
AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...
A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...
The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...
Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...
The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...
ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...
